May 10 (Reuters) - Telesta Therapeutics Inc TST.TO :
* Telesta Therapeutics publishes its Q3, 2016 financial
statements and provides corporate updates
* Qtrly net loss $1.6 million, compared to a net loss for
comparable period ending March 31, 2015 of $3.3 million
* Company continues to identify and implement opportunities
to reduce ongoing operating expenditures
* Board actively evaluating opportunities to create
shareholder value, through execution of one or more strategic
options
* Strategic options include sale of co, acquisition of
development-stage or commercial assets, merger of co with
another biotechnology co
Source text for Eikon:
Further company coverage: TST.TO
(Bengaluru Newsroom: +1-646-223-8780)